Cargando…
Granzyme B Contributes to the Optimal Graft-Versus-Tumor Effect Mediated by Conventional CD4(+) T Cells
Granzyme B (GzmB) is a key cytotoxic molecule utilized by T cells to kill pathogen-infected cells or transformed tumor cells. Previous studies using allogeneic hematopoietic cell transplantation (allo-HCT) murine models showed that GzmB is required for CD8(+) T cells to cause graft-versus-host disea...
Autores principales: | Du, Wei, Leigh, Nicholas D., Bian, Guanglin, Alqassim, Emad, O'Neill, Rachel E., Mei, Lin, Qiu, Jingxin, Liu, Hong, McCarthy, Philip L., Cao, Xuefang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5070611/ https://www.ncbi.nlm.nih.gov/pubmed/27774524 |
Ejemplares similares
-
Decreased granzyme-B expression in CD11c(+)CD8(+) T cells associated with disease progression in patients with HBV-related hepatocellular carcinoma
por: Gao, Lin, et al.
Publicado: (2023) -
Emerging Canonical and Non-Canonical Roles of Granzyme B in Health and Disease
por: Tibbs, Ellis, et al.
Publicado: (2022) -
Granzyme A–producing T helper cells are critical for acute graft-versus-host disease
por: Park, Sungtae, et al.
Publicado: (2020) -
Granzymes—Their Role in Colorectal Cancer
por: Pączek, Sara, et al.
Publicado: (2022) -
Granzyme A Is Required for Regulatory T-Cell Mediated Prevention of Gastrointestinal Graft-versus-Host Disease
por: Velaga, Sarvari, et al.
Publicado: (2015)